Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the appointment of Catherine Bovenizer as the Company’s Vice President of Finance, Chief Accounting Officer. Ms. Bovenizer brings over 20 years of experience in finance and accounting to the position with Apricus. She will report directly to Richard Pascoe, Apricus’ Chief Executive Officer, effective immediately.
